Market Cap
$33.64B$46.23M-0.14%
Summary
- Current Value
- As of today, RPRX market cap is $34B, down -0.14% in the most recent trading session on
- Category
- Based on its current market cap, RPRX falls into the Large Cap category
- Historical Performance
- RPRX market cap is up +103.07% year-to-date, up +122.95% over the past 365 days
- All-Time High Comparison
- RPRX market cap is currently -8.99% below its historical high of $37B set on
- 3-Year Low Comparison
- RPRX market cap is +210.59% above its 3-year low of $11B reached on
- Sector Comparison
- RPRX market cap is higher than 95.63% of companies in Healthcare sector
Market Cap Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $34B | -0.1% | -6.2% | +6.8% | +103.1% | +123.0% | +180.7% | +112.3% | |
| Price | $58.21 | -0.1% | -6.2% | +6.4% | +50.6% | +66.8% | +118.8% | +56.9% | |
| Shares Outstanding | 577.84M | +0.3% | – | – | – | +33.7% | +28.3% | +35.3% | |
| PE Ratio | 30.99 | -0.1% | -6.2% | +8.4% | +32.6% | +92.6% | -34.2% | +107.2% | |
| TTM Revenue | $2.54B | +3.9% | – | +3.9% | – | +10.0% | +7.4% | +13.3% | |
| TTM EPS | $1.88 | -1.8% | – | -1.8% | – | -13.4% | +232.5% | -24.3% | |
| $41.76B | -0.1% | -5.1% | +4.8% | +67.8% | +85.9% | +146.6% | +112.9% | ||
| TTM Dividend | $0.93 | 0.0% | 0.0% | +1.6% | +5.1% | +6.3% | +17.1% | +40.1% | |
| TTM Net Income | $1.35B | -0.8% | – | -0.8% | – | -19.0% | +186.7% | -31.0% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $37B | -9.0% | |
| 3M | $37B | -9.0% | |
| 6M | $37B | -9.0% | |
| 1Y | $37B | -9.0% | |
| 3Y | $37B | -9.0% | |
| 5Y | $37B | -9.0% | |
| All | $37B | -9.0% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $33B | +1.0% | |
| 3M | $31B | +6.8% | |
| 6M | $27B | +24.4% | |
| 1Y | $15B | +123.0% | |
| 3Y | $11B | +210.6% | |
| 5Y | $11B | +210.6% | |
| All | $11B | +210.6% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $34B | +103.1% | |
| $17B | +45.6% | |
| $11B | -9.3% | |
| $13B | -28.4% |
| Date | Value | Change |
|---|---|---|
| $18B | +1.5% | |
| $17B | -11.2% | |
| $19B | - |
FAQ
- What is the current market cap of RPRX?
- As of today, RPRX market cap is $34B
- What market cap category does RPRX fall into?
- Based on its current market cap, RPRX falls into the Large Cap category
- What is RPRX market cap today change?
- RPRX market cap is down -0.14% today
- What is 1-year change in RPRX market cap?
- RPRX market cap is up +122.95% year-over-year
- How far is RPRX market cap from its all-time high?
- RPRX market cap is currently -8.99% below its historical high of $37B set on September 4, 2026
- How does RPRX market cap rank versus sector peers?
- RPRX market cap is higher than 95.63% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx